Filed: 8/14/2026ACC: 0001315863-26-000592
📋 What this filing means
CRESTLINE MANAGEMENT, L.P. filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $53.48M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$53.48M
Total AUM (reported)
3.66M
Total Shares
Allocation by class
COM$53.48M100.0%
Portfolio Concentration
Top 3$53.48M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 3.66M
Sole
Full voting authority
3.66M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other3
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
DENALI THERAPEUTICS INC
DFNDShares1.91M
TypeSH
Market value$49.14M
91.90%
Sole
1.91M
Shared
0.00
None
0.00
SANA BIOTECHNOLOGY INC
DFNDShares755.74K
TypeSH
Market value$2.64M
4.93%
Sole
755.74K
Shared
0.00
None
0.00
8X8 INC NEW
DFNDShares990.85K
TypeSH
Market value$1.69M
3.17%
Sole
990.85K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DENALI THERAPEUTICS INCDFND | COM | 1.91M | SH | $49.14M 91.90% | 1.91M | 0.00 | 0.00 |
SANA BIOTECHNOLOGY INCDFND | COM | 755.74K | SH | $2.64M 4.93% | 755.74K | 0.00 | 0.00 |
8X8 INC NEWDFND | COM | 990.85K | SH | $1.69M 3.17% | 990.85K | 0.00 | 0.00 |